Evommune, Inc. (EVMN) › Capital ExpendituresEvommune, Inc. (EVMN) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2024: $88.0K2025: $235.0K$235.0K2024Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$235.0K+167.0%2024$88.0K—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share